Nano TransMed is an open access international, peer-reviewed journal dedicated to facilitating and expediting the translation of preclinical nanotechnology research into clinical applications, while fostering timely communication between researchers and clinicians.

The journal focuses on interdisciplinary and cross-boundary research between nano technology and pre-clinical/clinical applications, with the emphasis on both current and emerging innovative topics in translational medicine. These include preclinical applications of novel nanoscale materials, nano delivery system for stem cell-based therapy, nano fabrication and precise tissue engineering, as well as nanotechnology in pharmacology and pharmaceutics, diagnostics, targeted cancer therapy, translational outputs and evidence-based clinical outcomes of nano research. Exceptional non-nano works that hold substantial potential for future applications in nanomedicine will be considered on a case-by-case basis.

The journal welcomes original research papers, review articles, technical notes, editorials, and letters to the editor on matters that may benefit the wider readership of Nano TransMed.

Topics of interest include, but not limited to:

• Translational medicine;
• Nanomaterials;
• Nanomedicine;
• Nano-delivery system;
• Nano-fabrication;
• Tissue engineering;
• Engineered living systems;
• Advanced manufacturing;
• Smart medical appliances and device;
• Stem cells;
• Anodized therapies;
• 3D bioprinting;
• Organs-onchips;
• Microfluidics;
• Bioanalysis;
• Nanotechnology in pharmacology & pharmaceutics;
• Nanotechnology in diagnostics, targeted cancer therapy